CHEMOTHERAPY AND BCG IN TREATMENT OF DISSEMINATED MELANOMA - SOUTHWEST ONCOLOGY GROUP STUDY

被引:0
|
作者
COSTANZI, JJ [1 ]
机构
[1] UNIV TEXAS,MED BRANCH,GALVESTON,TX 77550
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:114 / 114
页数:1
相关论文
共 50 条
  • [1] COMBINATION CHEMOTHERAPY PLUS BCG IN THE TREATMENT OF DISSEMINATED MALIGNANT-MELANOMA - A SOUTHWEST ONCOLOGY GROUP-STUDY
    COSTANZI, JJ
    ALSARRAF, M
    GROPPE, C
    BOTTOMLEY, R
    FABIAN, C
    NEIDHART, J
    DIXON, D
    MEDICAL AND PEDIATRIC ONCOLOGY, 1982, 10 (03): : 251 - 258
  • [2] SEQUENTIAL COMBINATION CHEMOTHERAPY FOR DISSEMINATED MELANOMA - A SOUTHWEST ONCOLOGY GROUP-STUDY
    COSTANZI, J
    FABIAN, C
    WILSON, H
    DIXON, D
    CANCER TREATMENT REPORTS, 1981, 65 (7-8): : 732 - 734
  • [3] COMBINATION CHEMOTHERAPY PLUS LEVAMISOLE IN THE TREATMENT OF DISSEMINATED MALIGNANT-MELANOMA - A SOUTHWEST ONCOLOGY GROUP-STUDY
    COSTANZI, JJ
    FLETCHER, WS
    BALCERZAK, SP
    TAYLOR, S
    EYRE, HJ
    OBRYAN, RM
    ALSARRAF, M
    FRANK, J
    CANCER, 1984, 53 (04) : 833 - 836
  • [4] EVALUATION OF CIS-PLATINUM AND DTIC COMBINATION CHEMOTHERAPY IN DISSEMINATED MELANOMA - A SOUTHWEST ONCOLOGY GROUP-STUDY
    FLETCHER, WS
    GREEN, S
    FLETCHER, JR
    DANA, B
    JEWELL, W
    TOWNSEND, R
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1988, 11 (05): : 589 - 593
  • [5] A Phase II Trial of Pyrazine Diazohydroxide in Patients with Disseminated Malignant Melanoma and no Prior Chemotherapy – Southwest Oncology Group Study
    Robert P. Whitehead
    Joseph M. Unger
    Lawrence E. Flaherty
    Eric H. Kraut
    Glenn M. Mills
    Catherine E. Klein
    Robert A. Chapman
    Gary C. Doolittle
    Neel Hammond
    Vernon K. Sondak
    Investigational New Drugs, 2002, 20 : 105 - 111
  • [6] A phase II trial of pyrazine diazohydroxide in patients with disseminated malignant melanoma and no prior chemotherapy - Southwest Oncology Group study
    Whitehead, RP
    Unger, JM
    Flaherty, LE
    Kraut, EH
    Mills, GM
    Klein, CE
    Chapman, RA
    Doolittle, GC
    Hammond, N
    Sondak, VK
    INVESTIGATIONAL NEW DRUGS, 2002, 20 (01) : 105 - 111
  • [7] EVALUATION OF AMONAFIDE IN DISSEMINATED MALIGNANT-MELANOMA - A SOUTHWEST-ONCOLOGY-GROUP STUDY
    SLAVIK, M
    KOPECKY, KJ
    SONDAK, V
    CRAIG, JB
    SAMSON, MK
    INVESTIGATIONAL NEW DRUGS, 1993, 11 (2-3) : 223 - 226
  • [8] Phase II Trial of CI-980 in Patients with Disseminated Malignant Melanoma and no Prior Chemotherapy – A Southwest Oncology Group Study
    Robert P. Whitehead
    Joseph M. Unger
    Lawrence E. Flaherty
    John R. Eckardt
    Sarah A. Taylor
    Mukund S. Didolkar
    Wolfram Samlowski
    Vernon K. Sondak
    Investigational New Drugs, 2001, 19 : 239 - 243
  • [9] Phase II trial of CI-980 in patients with disseminated malignant melanoma and no prior chemotherapy - A Southwest Oncology Group study
    Whitehead, RP
    Unger, JM
    Flaherty, LE
    Eckardt, JR
    Taylor, SA
    Didolkar, MS
    Samlowski, W
    Sondak, VK
    INVESTIGATIONAL NEW DRUGS, 2001, 19 (03) : 239 - 243
  • [10] ADJUVANT CHEMOTHERAPY IN PRIMARY TREATMENT OF OSTEOGENIC SARCOMA - SOUTHWEST ONCOLOGY GROUP STUDY
    SUTOW, WW
    SULLIVAN, MP
    FERNBACH, DJ
    CANGIR, A
    GEORGE, SL
    CANCER, 1975, 36 (05) : 1598 - 1602